FY2025 · ended Sep 30, 2025 · Revenue $19.19M, -3.7% YoY · Filed Dec 19, 2025
cbdMD, Inc. (YCBD) files with the SEC under industry code 2844, Perfumes, Cosmetics & Other Toilet Preparations. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $19.2 million and a net loss of $2.0 million. Free cash flow was -$1.6 million. As of Jun 30, 2026 it held $2.1 million in cash and investments and $2.2 million in total debt.
Revenue (TTM)
$20.93M
+10.0% vs year-ago TTM
Net income (TTM)
$-2.89M
-90.8% vs year-ago TTM
Operating cash flow (TTM)
$-2.22M
-112.4% vs year-ago TTM
Free cash flow (TTM)
$-2.41M
-95.0% vs year-ago TTM
EPS
$-1.09
+92.4% vs prior year
Dividend per share
None
Shares outstanding
10.50M
+11.4% vs prior year
Net cash
$-70,337
as of Jun 30, 2026
Operating margin
-13.9%
FY 2026
Company profile
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Listed as
- YCBD (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NC
- Headquarters
- Charlotte, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644903
- Former names
- Level Brands, Inc. (until May 1, 2019); LEVEL BEAUTY GROUP, INC. (until Sep 27, 2016)
Other Perfumes, Cosmetics & Other Toilet Preparations companies
- Colgate Palmolive Co CL
- Haleon plc HLN
- Estee Lauder Companies Inc EL
- e.l.f. Beauty, Inc. ELF
- Interparfums Inc IPAR
- Coty Inc. COTY
- EDGEWELL PERSONAL CARE Co EPC
- Oddity Tech Ltd ODD
All 22 Perfumes, Cosmetics & Other Toilet Preparations companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $19.2M | $19.9M | $25.1M | $37.1M | $44.5M |
| Operating income | -$2.2M | -$3.3M | -$22.5M | -$78.3M | -$19.6M |
| Net income | -$2.0M | -$3.7M | -$22.9M | -$70.1M | -$23.4M |
| Diluted EPS | -$1.09 | -$14.29 | -$13.32 | -$55.80 | -$0.47 |
| Operating cash flow | -$1.5M | -$352,792 | -$4.3M | -$15.0M | -$14.1M |
| Free cash flow | -$1.6M | -$542,807 | -$4.6M | -$15.7M | -$14.4M |
| Total assets | $10.4M | $10.6M | $16.2M | $40.8M | $124.9M |
| Total liabilities | $3.2M | $8.6M | $7.2M | $9.4M | $21.7M |
| Stockholders' equity | $7.2M | $2.0M | $9.0M | $31.4M | $103.1M |
| Cash and investments | $2.3M | $2.5M | $1.8M | $6.7M | $26.4M |
| Total debt | $778,240 | $98,696 | $4.0M | $4.1M | $6.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 2, 2026 | Sep 1, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Apr 15, 2026 | Apr 14, 2026 |
All 538 cbdMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.